27material signals today 170IPOs 66buybacks 19OFSNSE · IST

Signals

18:59KAJARIACERBoard of Directors of the Company at its meeting held today, approved the Unaudited Financial Results for the…Major
18:56INDOTECHReceipt of Prestigious Order for Supply of Power Transformers for a Steel Plant in the Eastern Region of India
18:44GERMANFinancial results for the period ended Jun 30, 2026
18:15RAJOOENGUnaudited Consolidated and Standalone Financial Results of The Company for the Quarter and Half Year ended…
17:30LUMAXTECHPress release dated October 24, 2026, titled "Investor Release of Financial Results for the 2nd Quarter and…Major
17:25LUMAXTECHCapacity addition announced
17:09IDFCFIRSTBPress release dated October 24, 2026, titled "Press Release - Unaudited Standalone and Consolidated Financial…Major
16:35JKCEMENTQ2 FY27 results reportedMajor
16:33NETWEBPress release dated October 24, 2026, titled "Press release on the financial results for the quarter ended…
16:15MELSTARMemorandum of Understanding entered into between Melstarr Aviations Tech Private Limited ( MATPL ), a wholly…
15:58GLOBECIVILGeneral Updates with respect to ongoing litigation pertaining to the period prior to the listing of the…
15:54APOLLOFinancial results for the period ended September 30, 2026Major
15:38CASTROLINDFinancial results for the Quarter and Nine Months ended September 30, 2026
15:37VRLLOGHas submitted Letter of Offer pertaining to buyback of 87,50,000 equity shares of Rs. 10 each at a price of…Special Situation
15:34SESHAPAPERChairman's Letter to Shareholders - Un-audited Financial Results for the quarter and half-year ended…Major
15:27NECCLTDFinancial results for the period ended September 30, 2026Major
15:27CHEMBONDCHFinancial results for the period ended September 30, 2026
15:26AUBANKFinancial results for the period ended September 30, 2026Major
15:11GAELFinancial results for the period ended September 30, 2026Major
13:563PLANDFinancial results for the period ended September 30, 2026Major

Latest

Material developments from NSE, interpreted by CapitSignal.

Today

Thursday, 10 September 2026

Today Yesterday 7 days

28Material events 1Earnings 8Business 9Capital 4M&A 1Regulatory 5Distress

All Earnings

Edelweiss Financial Services LimitedEDELWEISS22:45MixedMinor

Edelweiss Financial Services approves public issue of secured NCDs up to ₹3,000 million

Capitalfundraise

As filed

Edelweiss Financial Services Limited has informed the Exchange regarding 'Public Issue Of Non-Convertible Debentures'.

Why it matters

CapitSignal interpretation

The filing sets out a potential ₹3,000 million public debt raise, creating an additional financing event for the company. The NCDs are proposed to be secured and listed on BSE, but the issue is not underwritten and the filing does not state the eventual subscription amount.

What happened

Fact

Edelweiss Financial Services’ Debenture Fund Raising Committee approved a public issue of up to 30,00,000 secured, redeemable, non-convertible debentures with a face value of ₹1,000 each. The issue comprises a ₹1,500 million base size and a green shoe option of up to ₹1,500 million, and is scheduled to open on September 21, 2026 and close on October 5, 2026.

₹1,500 millionBase issue size
Initial public issue size
Up to ₹1,500 millionGreen shoe option
Additional issue option
Up to ₹3,000 millionTotal issue limit
Cumulative base issue size and green shoe option
Up to 30,00,000Number of NCDs
Maximum number of debentures offered
₹1,000 eachFace value
Face value per NCD
Crisil A+/StableCredit rating
Rating assigned to the proposed NCDs
September 21, 2026 to October 5, 2026Issue period
Issue opening and closing dates

Watch next

Fact

Subscription levels through the October 5, 2026 issue closing date
Whether the green shoe option is exercised
Listing of the NCDs on BSE within three Working Days from issue closure and any rating revision or withdrawal

Full analysis Company memory

Shah Metacorp LimitedSHAH20:26MixedMinor

Shah Metacorp allots 2.75 crore shares to promoter on warrant conversion

Capitalpreferential allotment

As filed

Allotment of 2,75,00,000 (Two Crore Seventy-Five Lakhs) fully paid-up Equity Shares of face value of Re. 1/- each at an issue price of Rs. 4.71/- per share (including a premium of Rs. 3.71/- per share

Why it matters

CapitSignal interpretation

The conversion increases the company’s equity share capital by 2,75,00,000 shares and brings in the remaining conversion proceeds. The new shares are issued to a promoter and director and will rank pari passu with existing equity shares.

What happened

Fact

The board approved the allotment of 2,75,00,000 fully paid equity shares to promoter and director Ms. Mona Viral Shah following conversion of preferentially issued warrants. The company received the remaining 75% warrant consideration of ₹9,71,43,750, and its paid-up equity capital increased to ₹1,01,98,74,228 from ₹99,23,74,228.

2,75,00,000 equity sharesShares allotted
Equity shares issued upon conversion of warrants
₹4.71 per shareIssue price
Issue price, including ₹3.71 premium per share
₹9,71,43,750Balance conversion consideration received
75% balance consideration received for converted warrants
₹1,01,98,74,228Paid-up equity capital after allotment
Post-allotment paid-up equity share capital
1,01,98,74,228 sharesPost-allotment equity shares
Fully paid-up equity shares after allotment

Watch next

Fact

Any further conversions from the warrants originally allotted on June 26, 2025 and June 28, 2025
Changes in promoter shareholding following the allotment

Full analysis Company memory

Neogen Chemicals LimitedNEOGEN20:01MixedNotable

Neogen Chemicals opens QIP with ₹2,189.73 floor price

Update 1 of 3 in a matter ongoing since 10 Sept 2026

Capitalqip

As filed

Neogen Chemicals Limited has informed the Exchange about outcome of Fund Raising Committee meeting held on September 10, 2026.

Why it matters

CapitSignal interpretation

The company has formally commenced an equity capital raise from qualified institutional buyers. The eventual issue price, number of shares issued and total funds raised will determine the financing outcome and potential dilution for existing shareholders.

What happened

Fact

Neogen Chemicals’ Fund Raising Committee approved the preliminary placement document and opened a qualified institutions placement of equity shares on September 10, 2026. The floor price was set at ₹2,189.73 per share, with the company retaining discretion to offer a discount of up to 5%.

₹2,189.73 per Equity ShareQIP floor price
Floor price determined under the SEBI ICDR pricing formula
5%Maximum permitted discount
Maximum discount the company may offer on the floor price
₹10 eachEquity share face value
Face value of the shares offered through the QIP
September 10, 2026Relevant date
Relevant date fixed for the QIP

Watch next

Fact

Final issue price and whether a discount is offered
Number of equity shares issued and total proceeds raised
Completion of allotment to qualified institutional buyers

Full analysis Company memory

PAKKA LIMITEDPAKKA19:09Low

Pakka reports ₹51.09 crore received from ₹114.62 crore preferential issue

Capitalpreferential allotment

As filed

First Monitoring Agency Report for the quarter ended 30th June, 2026 - in relation to the Preferential issue of Equity shares and Fully Convertible warrants of Pakka Limited ( the Company )

Why it matters

CapitSignal interpretation

The report indicates that the proceeds received to date were being used in line with the issue’s stated objects. The filing also notes monitoring-agency observations and management’s response on the timing of the agency’s appointment and report submission.

What happened

Fact

Pakka Limited submitted Brickwork Ratings’ first monitoring report for the quarter ended June 30, 2026, covering proceeds from its preferential issue of equity shares and fully convertible warrants. The company had received ₹51.09 crore by June 30, 2026 against an aggregate issue size of ₹114.62 crore, and the monitoring agency reported no deviation from the stated objects of the issue.

₹51.09 crorePreferential issue proceeds received
proceeds received up to June 30, 2026
₹114.62 croreAggregate preferential issue size
equity shares and fully convertible warrants preferential issue

Watch next

Fact

Further receipt of the remaining preferential issue proceeds
Subsequent monitoring reports on utilization of proceeds
Any further disclosure regarding the monitoring-agency timing observations

Full analysis Company memory

Gabriel India Ltd.GABRIEL18:44MixedNotable

Gabriel India approves private placement of 1,00,000 unsecured debentures

Capitalfundraise

As filed

Gabriel India Limited has informed the Exchange regarding Outcome of Finance Committee Meeting held on September 10, 2026 regarding allotment of 1,00,000 (One Lakh) senior, unsecured, rated, listed, r

Why it matters

CapitSignal interpretation

The issuance creates unsecured debt obligations carrying an 8.15% annual coupon and redemption on September 10, 2029. The differing principal amount and issue size stated in the filing should be clarified.

What happened

Fact

Gabriel India’s Finance Committee approved the allotment of 1,00,000 senior, unsecured, rated, listed and redeemable non-convertible debentures on a private-placement basis. The filing states an aggregate principal amount of up to INR 10,00,00,00,000, while its annexure separately lists the issue size as INR 1,000,00,00,000.

1,00,000Debentures allotted
Number of non-convertible debentures
INR 1,00,000Face value per debenture
Face value
INR 10,00,00,00,000Aggregate principal amount
Aggregate principal amount stated in the main disclosure
INR 1,000,00,00,000Issue size
Issue size stated in Annexure A
8.15% per annumCoupon
Annual interest offered
36 monthsTenure
Period from deemed date of allotment
September 10, 2029Maturity date
Redemption date
BSE LimitedListing venue
Proposed listing venue

Watch next

Fact

Clarification of the difference between INR 10,00,00,00,000 and INR 1,000,00,00,000 stated in the filing.
Listing of the debentures on BSE Limited within the statutory timelines.
Annual coupon payments and redemption on September 10, 2029.

Full analysis Company memory

Precision Wires India LimitedPRECWIRE18:09Low

Precision Wires details conditional ₹10 crore land acquisition plan from preferential issue proceeds

Capitalpreferential allotment

As filed

Enclosed herewith additional disclosure in relation to the proposed acquisition of land as per the objects of the Preferential Issue.

Why it matters

CapitSignal interpretation

The disclosure clarifies a proposed use of preferential issue proceeds and highlights regulatory conditions around acquiring agricultural land. No specific land, transaction timeline or completed acquisition has been disclosed.

What happened

Fact

Precision Wires India said it may use up to ₹10 crore from its proposed preferential issue to acquire suitable land, subject to identification, due diligence, approvals and applicable laws. If agricultural land is acquired, the company will seek permission or conversion for non-agricultural use; if this is not obtained, it will dispose of the land as required by law.

Up to ₹10 croreLand acquisition allocation
Amount earmarked from proposed preferential issue proceeds for land purchase or acquisition

Watch next

Fact

Identification of the land and completion of legal and technical due diligence
Required approvals or non-agricultural-use conversion permission if agricultural land is acquired
Any material development or disclosure regarding the proposed acquisition

Full analysis Company memory

Madhya Bharat Agro Products LimitedMBAPL13:28DeterioratingMinor

Board reduces preferential issue proceeds allocated to Dhule manufacturing facility

Capitalpreferential allotment

As filed

Madhya Bharat Agro Products Limited has informed the Exchange regarding 'Restructuring the utilisation of proceeds from the Preferential Issue of Equity Shares '.

Why it matters

CapitSignal interpretation

The undersubscription reduces total available preferential issue proceeds and cuts the planned allocation for the new manufacturing facility at Dhule. The filing does not state whether the reduced capital expenditure allocation changes the project timeline or scope.

What happened

Fact

Madhya Bharat Agro Products said its Board approved restructuring the utilisation of preferential issue proceeds after certain proposed allottees undersubscribed the issue. The proposed allocation for the Dhule, Maharashtra manufacturing facility was reduced from Rs. 50,00,00,000 to Rs. 33,00,60,000, while working capital and general corporate purposes allocations remain unchanged.

Rs. 317,47,75,000 to Rs. 300,48,35,000Total issue proceeds
Existing and proposed total utilisation; reduction of Rs. 16,99,40,000 due to undersubscription
Rs. 50,00,00,000 to Rs. 33,00,60,000Dhule facility allocation
Capital expenditure for plant, machinery, equipment and civil construction; reduction of Rs. 16,99,40,000
Rs. 192,47,75,000Working capital allocation
Unchanged existing and proposed allocation
Rs. 75,00,00,000General corporate purposes allocation
Unchanged existing and proposed allocation

Watch next

Fact

Whether the Dhule manufacturing facility’s scope or implementation timeline is revised
Any further disclosure on the final preferential issue allotment and proceeds received

Full analysis Company memory

Ajmera Realty & Infra India LimitedAJMERA13:12MixedMinor

Ajmera Realty board approves proposed private placement of securities worth up to Rs. 500 Crores

Capitalfundraise

As filed

Ajmera Realty & Infra India Limited has informed the Exchange regarding Outcome of Board Meeting held on September 10, 2026 for consideration and approval of the proposal for Issuance of Non-Convertib

Why it matters

CapitSignal interpretation

The proposal could provide the company with additional funding capacity, but the filing does not disclose the intended use of proceeds, pricing, tenor, security, or other issuance terms. Member approval is still required before the proposed issuance can proceed.

What happened

Fact

Ajmera Realty & Infra India’s Board approved a proposal to issue non-convertible debentures, bonds or other instruments through private placement in one or more tranches. The aggregate issuance would not exceed Rs. 500 Crores and remains subject to approval by the company’s members.

Rs. 500 CroresProposed issuance size
Maximum aggregate amount of non-convertible debentures, bonds or other instruments proposed for private placement

Watch next

Fact

Member approval for the proposed issuance
Final terms, pricing, security, tenure and listing status of any instruments
Whether the securities are issued in one or more tranches

Full analysis Company memory

Mukka Proteins LimitedMUKKA10:35MixedNotable

Mukka Proteins allots 2 crore preferential convertible warrants worth Rs. 47 crore

Capitalpreferential allotment

As filed

Mukka Proteins Limited has informed the Exchange regarding allotment of 20000000 securities pursuant to Preferential Issue at its circular resolution dated September 09, 2026.

Why it matters

CapitSignal interpretation

The allotment provides Mukka Proteins with a preferential capital infusion while creating potential future equity dilution if the warrants are converted. The remaining 75% of the issue price is payable on conversion, which may provide additional funds within the stated 18-month period.

What happened

Fact

Mukka Proteins allotted 2,00,00,000 convertible warrants to identified non-promoter investors at an issue price of Rs. 23.50 per warrant, aggregating to Rs. 47 crore. Each warrant can be converted into one fully paid-up equity share within 18 months upon payment of the remaining 75% of the issue price; 25% was received upfront.

2,00,00,000Convertible warrants allotted
Total preferential warrants allotted
Rs. 23.50 per warrantIssue price
Preferential issue price
Rs. 47 croreAggregate issue size
Total value of warrants allotted
Rs. 5.88 per warrantUpfront subscription
25% upfront amount received per warrant
1 equity share per warrantConversion entitlement
Equity shares issuable on conversion
18 months from allotmentConversion period
Maximum period for exercising warrant conversion
Non-PromoterAllottee category
All 15 identified allottees are classified as non-promoter investors

Watch next

Fact

Whether warrant holders exercise their conversion rights within 18 months
Receipt of the remaining 75% of the issue price upon conversion
Any disclosures on the use of proceeds and resulting equity dilution

Full analysis Company memory